PML-RARα and Its Phosphorylation Regulate PML Oligomerization and HIPK2 Stability

被引:15
|
作者
Shima, Yutaka [1 ]
Honma, Yuki [1 ]
Kitabayashi, Issay [1 ]
机构
[1] Natl Canc Ctr, Div Hematol Malignancy, Chuo Ku, Tokyo 1040045, Japan
关键词
ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; RETINOID-X-RECEPTOR; T(15-17) TRANSLOCATION; TRANSCRIPTION FACTORS; NB4; CELLS; ACID; DIFFERENTIATION; DOMAINS; ACTIVATION;
D O I
10.1158/0008-5472.CAN-12-3814
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The PML gene is frequently fused to the retinoic acid receptor alpha (RAR alpha) gene in acute promyelocytic leukemia (APL), generating a characteristic PML-RAR alpha oncogenic chimera. PML-RAR alpha disrupts the discrete nuclear speckles termed nuclear bodies, which are formed in PML, suggesting that nuclear body disruption is involved in leukemogenesis. Nuclear body formation that relies upon PML oligomerization and its stabilization of the hypoxia-inducible protein kinase (HIPK)-2 is disrupted by expression of the PML-RAR alpha chimera. Here, we report that disruption of nuclear bodies is also mediated by PML-RAR alpha inhibition of PML oligomerization. PKAmediated phosphorylation of PML-RAR alpha blocked its ability to inhibit PML oligomerization and destabilize HIPK2. Our results establish that both PML oligomerization and HIPK2 stabilization at nuclear bodies are important for APL cell differentiation, offering insights into the basis for the most common prodifferentiation therapies of APL used clinically. (C) 2013 AACR.
引用
收藏
页码:4278 / 4288
页数:11
相关论文
共 50 条
  • [11] Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
    Zhang, Xiao-Wei
    Yan, Xiao-Jing
    Zhou, Zi-Ren
    Yang, Fei-Fei
    Wu, Zi-Yu
    Sun, Hong-Bin
    Liang, Wen-Xue
    Song, Ai-Xin
    Lallemand-Breitenbach, Valerie
    Jeanne, Marion
    Zhang, Qun-Ye
    Yang, Huai-Yu
    Huang, Qiu-Hua
    Zhou, Guang-Biao
    Tong, Jian-Hua
    Zhang, Yan
    Wu, Ji-Hui
    Hu, Hong-Yu
    de The, Hugues
    Chen, Sai-Juan
    Chen, Zhu
    SCIENCE, 2010, 328 (5975) : 240 - 243
  • [12] Relationship between degradation of PML-RARα and differentiation
    Naoe, T
    Kitamura, K
    BLOOD, 1999, 94 (04) : 1478 - 1478
  • [13] Quantitation of PML-RARα transcripts in APL patients
    Tobal, K
    LEUKEMIA, 2000, 14 (08) : 1530 - 1531
  • [15] PML-RARα kills U937 cells:: A novel activity of PML-RARα that may contribute to APL pathogenesis.
    Lane, AA
    Westervelt, P
    Ley, TJ
    BLOOD, 2002, 100 (11) : 538A - 538A
  • [16] Quantitation of PML-RARα transcripts in APL patients
    K Tobal
    Leukemia, 2000, 14 : 1530 - 1531
  • [17] Monitoring PML-RARα in acute promyelocytic leukemia
    Joseph G. Jurcic
    Current Oncology Reports, 2003, 5 (5) : 391 - 398
  • [18] A bcr-3 isoform of RARα-PML potentiates the development of PML-RARα-driven acute promyelocytic leukemia
    Pollock, JL
    Westervelt, P
    Kurichety, AK
    Pelicci, PG
    Grisolano, JL
    Ley, TJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15103 - 15108
  • [19] Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors
    GuiochonMantel, A
    Savouret, JF
    Quignon, F
    Delabre, K
    Milgrom, E
    DeThe, H
    ANNALES D ENDOCRINOLOGIE, 1996, 57 (02) : 91 - 100
  • [20] PML-RAR, A FUSION PROTEIN IN ACUTE PROMYELOCYTIC LEUKEMIA
    KAKIZUKA, A
    EVANS, RM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 214 - 214